KK
Kim P. Kamdar
Director

Kim P. Kamdar insider trades: Evofem Biosciences (EVFM) stock buys and sales

Director, Evofem Biosciences Last trade Dec 21, 2023 40 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2016
10
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kim reports to the SEC

and 4 more companies

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 21, 2023EVFM↓ Sell$6
Aug 15, 2023OMIC↓ Sell$362K
Jun 18, 2021EVFM↑ Buy$12K
Jun 12, 2020EVFM↑ Buy$15K
Aug 6, 2019OBLN↑ Buy$50K
May 21, 2019EVFM↓ Sell$3K
Aug 23, 2018OBLN↑ Buy$100K
Oct 12, 2016OBLN↑ Buy$201K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Kim P. Kamdar's insider trades

Kim P. Kamdar is a director at Evofem Biosciences (EVFM). Since Oct 12, 2016, Kim has reported 5 open-market purchases worth $377K and 3 sales worth $365K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (24 filings), other transactions (5 filings), shares returned to the company (5 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVFM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.